Write in a clean editor, then format for Alimentary Pharmacology & Therapeutics in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Alimentary Pharmacology & Therapeutics is a peer-reviewed journal published by Wiley, covering Inflammatory Bowel Disease, Helicobacter pylori-related gastroenterology studies, Gastrointestinal motility and disorders. Over its lifetime it has published 14,386 papers, which have received 551,568 citations.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Alimentary Pharmacology & Therapeutics 12 (3): 45–58.
Formats any DOI in Alimentary Pharmacology & Therapeutics style. No sign-up. |
| Publishes research in | Inflammatory Bowel Disease Helicobacter pylori-related gastroenterology studies Gastrointestinal motility and disorders Gastroesophageal reflux and treatments Liver Disease Diagnosis and Treatment |
| ISSN | 0269-2813 |
| Citation impact (2-yr) | 3.55 |
| h-index | 245 |
| i10-index | 7,610 |
| Article processing charge | $5,050 |
| Top institutions publishing here | Inserm |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Butyrate, a short-chain fatty acid, is a main end-product of intestinal microbial fermentation of mainly dietary fibre. Butyrate is an important energy source for intestinal epithelial cells and plays a role in the maintenance of colonic homeostasis. AIM: To provide an overview on the present knowledge of the bioactivity of butyrate, emphasizing effects and…
BACKGROUND: The clinical assessment and investigation of irritable bowel syndrome would be greatly facilitated by the introduction of a simple, easy to use severity scoring system. Such a system, developed in our department over a number of years, has been submitted to validation in a total of 141 patients and 40 healthy controls. METHODS: The…
Significant progress and new insights have been gained in the 4 years since the first Maastricht Consensus Report, necessitating an update of the original guidelines. To achieve this, the European Helicobacter Pylori Study Group organized a meeting of specialists and experts from around the world, representatives from National Gastroenterology Societies and general practitioners from Europe…
BACKGROUND: There is little published evidence on the gastrointestinal features of COVID-19. AIMS: To report on the gastrointestinal manifestations and pathological findings of patients with COVID-19, and to discuss the possibility of faecal transmission. METHODS: We have reviewed gastrointestinal features of, and faecal test results in, COVID-19 from case reports and retrospective clinical studies relating…
BACKGROUND: A majority of studies investigating the accuracy of ultrasound for detecting hepatocellular carcinoma (HCC) do not reflect how this test is used for surveillance vs. diagnosis. AIM: To determine the performance characteristics of surveillance with ultrasound for the detection of HCC, particularly early HCC as defined by the Milan criteria. METHODS: A systematic literature…
